As a well-known factor in regulating cell growth, proliferation, and inflammation, galectin-3 was recently shown as a novel biomarker correlated with CKD progression as well as clinical adverse outcomes [12,13]. The gene discussed is LGALS3; the disease is chronic kidney disease.